Protein cysteine S-nitrosylation inhibits vesicular uptake of neurotransmitters

Neuroscience ◽  
2015 ◽  
Vol 311 ◽  
pp. 374-381 ◽  
Author(s):  
Y. Wang ◽  
Z. Zhou ◽  
T. Leylek ◽  
H. Tan ◽  
Y. Sun ◽  
...  
Keyword(s):  
2020 ◽  
Author(s):  
Carlie A. Hoffman ◽  
Meghan Bucher ◽  
Joshua M. Bradner ◽  
Lauren Jones ◽  
Kenny Igarza ◽  
...  

This manuscript outlines a high-throughput 96-well plate assay to measure the vesicular uptake of the false fluorescent neurotransmitter FFN206 by the vesicular monoamine transporter 2 (VMAT2) in near real-time and following pharmacological and environmental toxicant exposure in HEK293 cells.


2017 ◽  
Vol 61 (4) ◽  
Author(s):  
Wisith Tun-Yhong ◽  
Chatchai Chinpaisal ◽  
Perayot Pamonsinlapatham ◽  
Sindchai Kaewkitichai

ABSTRACT Tenofovir disoproxil fumarate (TDF), a nucleotide reverse transcriptase inhibitor, after conversion to tenofovir (TFV), is mainly eliminated by glomerular filtration and active tubular secretion. The major adverse effect of tenofovir is nephrotoxicity; however, the exact mechanism remains poorly understood. In this study, the ATP-binding cassette subfamily C member 11 (ABCC11; multidrug resistance protein 8 [MRP8]) transporter, which is abundant in proximal tubular cells, was demonstrated to act as an efflux transporter of tenofovir. Real-time PCR (RT-PCR) and indirect immunofluorescence assays were used to determine MRP8 overexpression in a continuous cell line. Tenofovir accumulations were assessed by cytotoxicity, cellular transport, and vesicular uptake assays. Substrate specificity was confirmed using MK-571, an MRP-specific inhibitor, and methotrexate, which served as a known substrate. Intracellular and intravesicular concentrations of tenofovir were determined by liquid chromatography-tandem mass spectrometry (LC-MS/MS). The 50% cytotoxic concentration (CC50) of TDF in MRP8-overexpressing cells was 4.78 times higher than that of parental cells. Transport assays also showed that the intracellular accumulation of tenofovir in MRP8-overexpressing cells was 55 times lower than that in parental cells and was partly reversed by MK-571. Similarly, an “inside-out” vesicular uptake assay, using Sf9 inverted membrane vesicles to allow measuring of accumulation of the substrates into the vesicles, demonstrated a higher intravesicular concentration of tenofovir in MRP8-overexpressing vesicles than in Sf9 insect control vesicles. These effects were effectively reversed by increasing concentrations of the specific inhibitor MK-571. In conclusion, tenofovir is a new substrate of the MRP8 transporter. An alteration in the activity of this efflux pump may increase the intracellular accumulation of tenofovir in proximal renal tubular cells.


Placenta ◽  
2016 ◽  
Vol 45 ◽  
pp. 112
Author(s):  
Margarita Sharshiner ◽  
Cecilia Cheung ◽  
Robert Brace

1992 ◽  
Vol 593 (1) ◽  
pp. 32-38 ◽  
Author(s):  
Laurent Naudon ◽  
Isabelle Leroux-Nicollet ◽  
Jean Costentin

Life Sciences ◽  
2002 ◽  
Vol 71 (19) ◽  
pp. 2227-2237 ◽  
Author(s):  
Netta Roz ◽  
Yehuda Mazur ◽  
Amiram Hirshfeld ◽  
Moshe Rehavi
Keyword(s):  

2020 ◽  
Author(s):  
Carlie A. Hoffman ◽  
Meghan Bucher ◽  
Joshua M. Bradner ◽  
Lauren Jones ◽  
Kenny Igarza ◽  
...  

This manuscript outlines a high-throughput 96-well plate assay to measure the vesicular uptake of the false fluorescent neurotransmitter FFN206 by the vesicular monoamine transporter 2 (VMAT2) in near real-time and following pharmacological and environmental toxicant exposure in HEK293 cells.


Sign in / Sign up

Export Citation Format

Share Document